Clinical Instructor
General Surgery, Breast Division, Samsung Medical Center

Speciality Interests

Breast cancer, Robotic breast surgery, Hereditary breast cancer

Schedule

schedule of week
12 MON
16
TUE
17
WEN
18
THU
19
FRI
20
AM available available
PM available

Medical School

2017.3~2019.8 Ph.D. in Medicine Sungkyunkwan University School of Medicine, Korea 2010.3~2016.8 Master of Science Sungkyunkwan University School of Medicine, Korea 2001.3~2007.2 Medical Doctor Yeungnam University School of Medicine, Korea

Specialty Training

Specialty Training
Fellowship   2015.5~2018.2 Division of Breast Surgery, Department of General Surgery Samsung Medical Center
Residency   2008.3-2012.2 Department of General Surgery, Samsung Medical Center
Internship   2007.3-2008.2 Yeungnam University Hospital

Other Education

  • 2022.03~Present Associate Professor Division of Breast Surgery, Department of General Surgery, Samsung Medical Center
    2020.03~2022.2 Assistant Professor Division of Breast Surgery, Department of General Surgery, Samsung Medical Center
    2018.03~2020.2 Clinical Instructor Division of Breast Surgery, Department of General Surgery, Samsung Medical Center
    2014.5~2015.4 Military Service Forensic doctor, Minister of National Defense, Republic of Korea
    2012.2~2014.4 Military Service Medical company commander, 1st division of Military Army Surgeon, Republic of Korea

Participation in Academic Societies
and Research

  • 2022~Present Secretary of International Committee Korean Society of Surgical Oncology
    2022~Present Member of Commission on Policy Planning Committee Korean Society of Surgical Oncology
    2022~Present Member of Breast division of Special Committee Korean Society of Endo-Laparoscopic & Robotic Surgery (KSERS)
    2021~Present Secretary of International Committee Korean Breast Cancer Society
    2021~Present Member of Academic Program Committee and Scientific Program Committee The Korean Association of RObotic Surgeons (KAROS)
    2020~2021 Secretary of Academic Program Committee and Scientific Program Committee Global Breast Cancer Conference (GBCC), Korean Breast Cancer Society
    2020~2021 Member of Finance Committee Korean Society of Surgical Oncology
    2019~Present Chair of Academic Committee Korean Robot and Endoscopic Minimal Access Breast Surgery Study Group (KoREa-BSG), Korean Breast Cancer Society
    2019~Present Member of Academic Program Committee and Scientific Program Committee Global Breast Cancer Conference, Korean Breast Cancer Society
    2019~Present Member of Educational Program Committee Korean Breast Cancer Society
    2019~Present Member of International Committee Korean Breast Cancer Society
    2019~Present Member of Protocol Development Group Committee Korean Breast Cancer Society
    2018~Present Member of Korean Clinical Practice Guideline Committee Korean Breast Cancer Society
    2017~Present Member of Korean Hereditary Breast Cancer Study Group Korean Breast Cancer Society
    2018~Present Member Korean Society of Surgical Oncology
    2018~Present Member Korean Society of Lymphedema
    2018~Present Member of IRB Committee Samsung Medical Center
    2015~Present Member Korean Breast Cancer Society
    2012~Present Member Korean Surgical Society

Thesis

  • EJSO-EUR J SURG ONC 2024 10.1016/j.ejso.2024.108644 Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes Park, WK; Kim, HJ; Ryu, JM; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • CANCER-AM CANCER SOC 2024 10.1002/cncr.35567 Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy Shin, DS; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • EJSO-EUR J SURG ONC 2024 10.1016/j.ejso.2024.108602 Learning curve for robot-assisted nipple-sparing mastectomy: A single institution experience Jung, SM; Kim, YJ; Lee, KT; Jeon, BJ; Mun, GH; Pyon, JK; Ryu, JM
    View PubMed
  • JAMA SURG 2024 10.1001/jamasurg.2024.2977 Minimal Access vs Conventional Nipple-Sparing Mastectomy Kim, JH; Ryu, JM; Bae, SJ; Ko, BS; Choi, JE; Kim, KS; Cha, C; Choi, YJ; Lee, HY; Nam, SE; Kim, Z; Kang, YJ; Lee, MH; Lee, JE; Park, E; Shin, HJ; Kim, MK; Choi, HJ; Kwon, SU; Son, NH; Park, HS; Lee, JY
    View PubMed
  • CANCERS 2024 10.3390/cancers16142566 The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Ryu, JM; Chae, B
    View PubMed
  • ASIA-PAC J CLIN ONCO 2024 10.1111/ajco.14074 Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia Kwong, A; Tan, DSP; Ryu, JM
    View PubMed
  • CANCERS 2024 10.3390/cancers16101865 The Effects of National Insurance Coverage Expansion and Genetic Counseling's Role on BRCA1/2 Mutation Tests in Breast Cancer Patients Jang, SY; Kwak, Y; Choi, JY; Shin, DS; Lee, H; Kim, M; Jung, BY; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • NPJ PRECIS ONCOL 2024 10.1038/s41698-024-00559-0 Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations Park, WK; Chung, SY; Jung, YJ; Ha, C; Kim, JW; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, JE; Kim, SW; Ryu, JM
    View PubMed
  • BREAST CANCER RES 2024 10.1186/s13058-024-01807-8 Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study Bae, SJ; Chun, JW; Lee, SB; Ryu, JM; Nam, SJ; Jeong, J; Park, HS; Ahn, SG
    View PubMed
  • J BREAST CANCER 2024 10.4048/jbc.2023.0264 Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/TripleNe-gative Breast Cancer Patients With Excellent Response Ryu, JM; Lee, H; Han, W; Lee, HB; Ahn, SG; Kim, HJ; Park, HS; Choi, JS; Kim, H; Cho, WK; Lee, JE
    View PubMed
  • FAM CANCER 2024 10.1007/s10689-024-00379-y Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review Afaya, A; Kim, SW; Park, HS; Lim, MC; Jung, MS; Nam, EJ; Park, JS; Jeong, J; Ryu, JM; Kim, J; Kim, J; Kim, M; Jin, J; Han, J; Kim, SY; Park, SY; Katapodi, MC; Kim, S
    View PubMed
  • BMC WOMENS HEALTH 2024 10.1186/s12905-024-02973-9 Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients Kim, EY; Lee, KH; Yun, JS; Park, YL; Park, CH; Jang, SY; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, JH
    View PubMed
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9 Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
    View PubMed
  • INT J SURG 2024 10.1097/JS9.0000000000000907 Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study Bae, SJ; Kim, HJ; Kim, HA; Ryu, JM; Park, S; Lee, EG; Im, SA; Jung, YS; Park, MH; Park, KH; Kang, SH; Park, E; Kim, SY; Lee, MH; Kim, LS; Lee, AB; Noh, WC; Gwark, S; Kim, S; Jeong, J
    View PubMed
  • J BREAST CANCER 2024 10.4048/jbc.2023.0265 Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial Jung, JJ; Cheun, JH; Kim, SY; Koh, J; Ryu, JM; Yoo, TK; Shin, HC; Ahn, SG; Park, S; Lim, W; Nam, SE; Park, MH; Kim, KS; Kang, T; Lee, J; Youn, HJ; Kim, YS; Yoon, CI; Kim, HK; Moon, HG; Han, W; Cho, N; Kim, MK; Lee, HB
    View PubMed
  • J BREAST CANCER 2024 10.4048/jbc.2023.0196 Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort Shin, DS; Bang, YJ; Choi, JY; Jang, SY; Lee, H; Kwak, Y; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Jeon, BJ; Pyon, JK; Mun, GH; Lee, KT; Ryu, JM
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15225361 The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ
    View PubMed
  • J CLIN ONCOL 2023 10.1200/JCO.23.00557 Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial Baek, SY; Noh, WC; Ahn, SH; Kim, HA; Ryu, JM; Kim, SI; Lee, EG; Im, SA; Jung, YS; Park, MH; Park, KH; Kang, SH; Jeong, J; Park, E; Kim, SY; Lee, MH; Kim, LS; Lim, W; Kim, S; Kim, HJ
    View PubMed
  • JAMA NETW OPEN 2023 10.1001/jamanetworkopen.2023.42270 Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma Yoon, TI; Jeong, J; Lee, S; Ryu, JM; Lee, YJ; Lee, JY; Hwang, KT; Kim, H; Kim, S; Lee, SB; Ko, BS; Lee, J; Son, BH; Metzger, O; Kim, HJ
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1230310 Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15184485 Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring BRCA1/BRAC2 Pathogenic Variants: A Web-Based Platform for Cascade Genetic Testing Baroutsou, V; Duong, V; Signorini, A; Saccilotto, R; Ciorba, FM; Bürki, N; Caiata-Zufferey, M; Ryu, JM; Kim, SW; Lim, MC; Monnerat, C; Zürrer-Härdi, U; Kim, J; Heinimann, K; Graffeo, R; Park, JS; Rabaglio, M; Chappuis, PO; Kim, S; Katapodi, MC; CASCADE and K CASCADE Consortia
    View PubMed
  • WORLD J CLIN CASES 2023 10.12998/wjcc.v11.i27.6398 Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY
    View PubMed
  • JMIR PUBLIC HLTH SUR 2023 10.2196/45212 Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.105.1.10 Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15133435 Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • BMC CANCER 2023 10.1186/s12885-023-10978-0 Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG) Ryu, JM; Lee, J; Lee, JY; Ko, BM; Kim, JH; Shin, H; Park, HS
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e17 Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level Ryu, JM; Kang, DB; Cho, JH; Lee, JE; Kim, SW; Nam, SJ; Lee, SK; Kim, YJ; Im, YH; Ahn, JS; Park, YH; Kim, JY; Lee, HYJ; Kang, MR; Yu, JH
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e11 Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study Yeo, SM; Lim, JY; Kim, SW; Chae, BJ; Yu, JH; Ryu, JM; Hwang, JH
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1039670 The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW
    View PubMed
  • CANCERS 2023 10.3390/cancers15051556 Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.104.3.137 The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH
    View PubMed
  • BRIT J SURG 2023 10.1093/bjs/znad006 Robot-assisted mastectomy: next major advance in breast cancer surgery Toesca, A; Park, HS; Ryu, JM; Kim, YJ; Lee, J; Sangalli, C; Maisonneuve, P; Marrazzo, E; Pozzi, G; Gazzetta, G; Montemurro, F; Corso, G; Lissidini, G; Caldarella, P; Mazzotta, E; Massari, G; Veronesi, P
    View PubMed
  • ANN SURG TREAT RES 2022 10.4174/astr.2022.103.6.323 Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant Bang, YJ; Kwon, WK; Kim, JW; Lee, JE; Jung, BY; Kim, M; Kim, J; An, J; Jung, SP; Kim, HK; Kim, Z; Youn, HJ; Ryu, JM; Kim, SW
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12389-0 Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter? Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, J; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12602-0 ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter? Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, JH; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e49 Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • J CLIN MED 2022 10.3390/jcm11216564 Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.901 Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH
    View PubMed
  • CANCERS 2022 10.3390/cancers14194839 Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12075-1 ASO Visual Abstract: Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction-International Multicenter Pooled Data Analysis Park, HS; Lee, J; Lai, HW; Park, JM; Ryu, JM; Lee, JE; Kim, JY; Marrazzo, E; De Scalzi, AM; Corso, G; Montemurro, F; Gazzetta, G; Pozzi, G; Toesca, A
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e36 Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.784 Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.791 Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE
    View PubMed
  • WORLD J SURG ONCOL 2022 10.1186/s12957-022-02673-4 Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis Cha, C; Kim, EY; Kim, SY; Ryu, JM; Park, MH; Lee, S; Suh, YJ; Choi, N; Hong, H; Kim, HS; Chung, MS
    View PubMed
  • CANCER GENET-NY 2022 10.1016/j.cancergen.2022.05.042 Discovery of BRCA1/BRCA2 founder variants by haplotype analysis Kwon, WK; Jang, HJ; Lee, JE; Park, YH; Ryu, JM; Yu, J; Jang, JH; Kim, JW
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-11865-x Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis Park, HS; Lee, J; Lai, HW; Park, JM; Ryu, JM; Lee, JE; Kim, JY; Marrazzo, E; De Scalzi, AM; Corso, G; Montemurro, F; Gazzetta, G; Pozzi, G; Toesca, A
    View PubMed
  • CURR ONCOL 2022 10.3390/curroncol29050267 Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE
    View PubMed
  • ANN SURG 2022 10.1097/SLA.0000000000004492 Robot-assisted Nipple-sparing Mastectomy With Immediate Breast Reconstruction An initial Experience of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) Ryu, JM; Kim, JY; Choi, HJ; Ko, B; Kim, J; Cho, J; Lee, MH; Choi, JE; Kim, JH; Lee, J; Jung, SM; Shin, HJ; Lee, J; Park, HS
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e17 Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society Ryu, JM; Choi, HJ; Park, EH; Kim, JY; Lee, YJ; Park, S; Lee, J; Park, HK; Nam, SJ; Kim, SW; Lee, JH; Lee, JE
    View PubMed
  • BMC CANCER 2022 10.1186/s12885-022-09273-1 No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial Jung, JG; Ahn, SH; Lee, S; Kim, EK; Ryu, JM; Park, S; Lim, W; Jung, YS; Chung, IY; Jeong, J; Chang, JH; Shin, KH; Chang, JM; Moon, WK; Han, W
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-00278-7 From cadaveric and animal studies to the clinical reality of robotic mastectomy: a feasibility report of training program Lee, J; Park, HS; Lee, DW; Song, SY; Yu, J; Ryu, JM; Bae, SJ; Lew, DH; Kim, SI; Toesca, A
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10204754 Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • ANN SURG TREAT RES 2021 10.4174/astr.2021.101.3.131 Comparison of clinicopathological characteristics and prognosis in breast cancer patients with different Breast Imaging Reporting and Data System categories Kim, BK; Ryu, JM; Oh, SJ; Han, J; Choi, JE; Jeong, J; Suh, YJ; Lee, J; Sun, WY
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e30 Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-96855-x Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients Cho, SY; Lee, JH; Ryu, JM; Lee, JE; Cho, EY; Ahn, CH; Paeng, K; Yoo, I; Ock, CY; Song, SY
    View PubMed
  • J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e194 Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-94195-4 Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.691277

    Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea

    Lee1, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

    J BREAST CANC 2021 10.4048/jbc.2021.24.e16

    Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations

    Alyami1, H; Yoo, TK; Cheun, JH; Lee, HB; Jung, SM; Ryu, JM; Bae, SJ; Jeong, J; Yoon, CI; Ahn, J; Paik, PS; Cho, MK; Park, WC

    BMC SURG 2021 10.1186/s12893-021-01129-y

    The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial

    Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW

    J BREAST CANC 2021 10.4048/jbc.2021.24.e4

    Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer

    Min1, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ

    FRONT ONCOL 2021 10.3389/fonc.2021.588728

    Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer

    Kwon1, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE

    EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023

    Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer

    Woo1, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

    BMC CANCER 2021 10.1186/s12885-020-07729-w

    Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?

    Jung1, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE

    Japanese journal of clinical oncology./2020.02

    Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors

    Jai Min Ryu 1 1, Seok Jin Nam 1 , Seok Won Kim 1 , Jeong Eon Lee 1 , Byung Joo Chae 1 , Se Kyung Lee 1 , Jonghan Yu 1

    Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant /2020.07.31

    Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant

    Hyung Seok Park 1 1, Jai Min Ryu 2 , Ji Soo Park 3 , Seock-Ah Im 4 5 , So-Youn Jung 6 , Eun-Kyu Kim 7 8 , Woo-Chan Park 9 , Jun Won Min 10 , Jeeyeon Lee 11 , Ji Young You 12 , Jeong Eon Lee 2 , Sung-Won Kim 13

    JAMA SURG 2020 10.1001/jamasurg.2020.4124

    Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence

    Lee1, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI

    J BREAST CANC 2020 10.4048/jbc.2020.23.e61

    Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation

    Jung1, SM; Ryu, JM; Park, HS; Park, JS; Kang, E; Lee, S; Lee, HB; Youn, HJ; Yoo, TK; Kim, J; Lee, JE; Han, SA; Kim, D; Kim, SW

    ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251

    Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?

    Jung1, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE

    BREAST CANCER RES TR 2020 10.1007/s10549-020-05952-4

    Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women

    Park1, JW; Han, KD; Shin, DW; Yeo, Y; Chang, JW; Yoo, JE; Jeong, SM; Lee, SK; Ryu, JM; Park, YM

    NUTRIENTS 2020 10.3390/nu12092831

    Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients

    Kim1, JA; Choi, R; Won, H; Kim, S; Choi, HJ; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Lee, SY

    CANCER RES TREAT 2020 10.4143/crt.2019.351

    Clinicopathological Features of Patients with the BRCA1 c.5339T > C (p.Leu1780Pro) Variant

    Park1, HS; Ryu, JM; Park, JS; Im, SA; Jung, SY; Kim, EK; Park, WC; Min, JW; Lee, J; You, JY; Lee, JE; Kim, SW

    J CLIN MED 2020 10.3390/jcm9041192

    Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence

    Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK

    JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147

    Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors

    Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J

    J BREAST CANC 2019 10.4048/jbc.2019.22.e48

    Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm

    Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE

    BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y

    Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

    Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK

    ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169

    Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer

    Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK

    EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011

    A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning

    Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

    BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4

    Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

    Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW

    NUTRIENTS 2019 10.3390/nu11010037

    Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients

    Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY

    Breast Cancer Res Treat./ 2018 Sep 14.

    Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer.

    Ryu JM1, Choi HJ, Kim I, Lee SK, Yu J, Kim JE, Kang BI, Lee JE, Nam SJ, Kim SW.

    Breast Cancer Res Treat. /2018 Oct 22

    Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

    Ryu JM1, Choi HJ, Kim I, Nam SJ, Kim SW, Yu J, Lee SK, Choi DH, Park YH, Kim JW, Seo JS, Park JH, Lee JE, Kim SW

    J BREAST CANC 2018 10.4048/jbc.2018.21.e54

    Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis

    Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

    BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y

    Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer

    Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW

    J BREAST CANC 2018 10.4048/jbc.2018.21.e50

    Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study

    Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

    J BREAST CANC 2018 10.4048/jbc.2018.21.2.222

    Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer

    Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

    J BREAST CANC 2018 10.4048/jbc.2018.21.2.173

    Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer

    Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

    WORLD J SURG 2018 10.1007/s00268-017-4342-7

    Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer

    Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ

    CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003

    Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane

    Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ

    Breast/ 2017 Jun

    Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea

    Ryu JM1, Kang G, Nam SJ, Kim SW, Yu J, Lee SK, Bae SY, Park S, Paik HJ, Kim JW, Park SS, Lee JE, Kim SW.

    Breast Cancer Res Treat/. 2017 Dec

    Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society

    Ryu JM1, Yu J, Kim SI, Kim KS, Moon HG, Choi JE, Jeong J, Do Byun K, Nam SJ, Lee JE, Lee SK, Kim SW.

    Clin Breast Cancer 2017 Nov

    Predictive factors for nonsentinel lymph node metastasis in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.

    Ryu JM1, SK Lee, JY Kim, HJ Paik, S Park, J Yu, SW Kim, JE Lee, SY, Bae, SW Han, YS Jung, SJ Nam

    J Breast Cancer/2017 March

    Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study.

    Ryu JM1, Paik HJ, Park S, Yi HW, Nam SJ, Kim SW, Lee SK, Yu J, Bae SY, Lee JE.

    Clin Breast Cancer 2017 June

    Oncologic safety of immediate breast reconstruction in breast cancer patients who underwent neoadjuvant chemotherapy: Short-term outcomes of a matched case control study.

    JM Ryu1, S Park, HJ Paik, SJ Nam, SW Kim, SK Lee, J Yu, SY Bae, I Kim, SI Bang, GH Mun, JK Pyon, BJ Jeon, JE Lee

    Breast. 2016 Dec

    Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype.

    Alramadhan M1, Ryu JM, Rayzah M, Nam SJ, Kim SW, Yu J, Lee SK, Bae SY, Park S, Paik HJ, Lee JE

    Breast Cancer Res Treat /2017 Feb

    Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society.

    Ryu JM1, HJ Lee, TI Yoon, ES Lee, SJ Lee, JH Jung, BJ Chae, SJ Nam, JE Lee, SK Lee, SY Bae, J Yu, SW Kim

    World J Surg. 2016 Aug

    Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm.

    Ryu JM1, Nam SJ, Kim SW, Lee SK, Bae SY, Yi HW, Park S, Paik HJ, Lee JE.

    CLOSE

    Patients' Rights and Responsibilities

    Patients' Rights

    1. Right to receive medical care

    Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

    2. Right to be informed and to make an autonomous decision

    Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

    3. Right to confidentiality

    Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

    4. Right to request consultation and mediation

    In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

    5. Right to have values and beliefs respected

    Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

    6. Right to receive care in a safe setting

    Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

    Patients' Responsibilities

    1. Responsibility to trust and respect the medical team

    Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

    2. Responsibility to not use dishonest methods for medical treatment

    Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

    3. Responsibility to abide by all hospital regulations

    Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.